Archives

Immune responses to SARS-CoV-2

From: Howard Hughes Medical Institute, Yale University School of Medicine, Department of Immunobiology, New Haven (US) Host contact: Roger Geiger Date: 18.11.2021 16:30 Speakers: Akiko Iwasaki Virtual Conference

Engineered bacteria for cancer immunotherapy

Bellinzona, October 6th, 2021 – A Nature paper by the Systems Immunology group, headed by Roger Geiger, at the Institute for Research in Biomedicine (IRB, affiliated to USI). This study describes an innovative strategy to improve the anti-tumor activity of T cells, key players of the immune system with the ability to detect and kill […]

New SNSF grants awarded to three IRB researchers

Bellinzona – September 28, 2021 – The Swiss National Science Foundation (SNSF) has recently awarded three group leaders at the Institute for Research in Biomedicine (IRB, affiliated to USI): Silvia Monticelli, Santiago González and Petr Cejka. Silvia Monticelli, director of the Molecular Immunology lab, is interested in studying gene expression regulation in immune cells at […]

The IRB Student Association (ISA) is born

24.09.2021 – The IRB warmly welcome the newly created IRB Student Association (ISA). The association’s main aim is to promote interaction between IRB students, facilitate student life, and advocate the interests of students. The IRB thanks Emina, Elaheh, Irene, Serena, Julia, Edisa, Giulia, Tommaso and Ian, members of the ISA steering committee.  

First peptide inhibitor of the CXCL12/HMGB1 heterocomplex identified

During inflammatory reactions, the production and release of chemotactic factors guide the recruitment of selective leukocyte subpopulations. The chemokine CXCL12 and the alarmin HMGB1, both released in the microenvironment, can form a heterocomplex, which exclusively acts on the chemokine receptor CXCR4, enhancing cell migration and, in some pathological conditions such as Rheumatoid Arthritis exacerbates the […]

The Association Bellinzona Institutes of Science (Bios+) is born

Bellinzona, September 15th, 2021 – the Foundations of the Institute for Research in Biomedicine (IRB) and the Institute of Oncology Research (IOR) presented the newly formed association Bellinzona Institutes of Science (Bios+), which was established by the two Institutes on July 21st with the aim of promoting and coordinating research activities and creating scientific and […]

IRB ready for clinical testing of second generation antibody against COVID-19

Bellinzona, September 7, 2021 – Following the development of a second-generation antibody against the novel coronavirus (SARS-CoV-2) and its variants, the Institute for Research in Biomedicine (IRB, affiliated to USI) is now moving into the clinical trial phase, supported by the European Commission. Described in a paper published in March in the prestigious journal Nature, […]

A Single Vaccine Against Coronaviruses is a step closer

Bellinzona, August 6th 2021 – The spillovers of β-coronaviruses in humans and the emergence of SARS-CoV-2 variants highlight the need for broad coronavirus countermeasures.   A study co-authored by Dr. Jun Siong Low, Postdoc at the Cellular Immunology lab directed by Prof. Federica Sallusto at IRB (Institute for Research in Biomedicine, affiliated to USI) and […]

Antonino Cassotta awarded the SAIS prize for best PhD thesis in life science

June 28, 2021: The Società degli Accademici italiani in Svizzera (SAIS) awards Italian students that pursued their PhD in Switzerland by offering three prizes for the best doctoral theses, one for each of these fields: 1) STEM (Science, Technology, Engineering and Mathematics), 2) life sciences, and 3) human sciences (social, political and legal sciences). On […]